Institutional Ownership
An2 Therapeutics Inc
CUSIP 037326105COMANTXQ1 2026
Institutional Holders
49
13F filers
Shares Held
20.74M
Aggregate institutional
Institutional Value
$70.71M
Q1 2026
Net New Holders
+14
22 new · 8 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions22
Increased13
Decreased8
Sold out8
Institutional Holders
49 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 3.15M | $10.79M | +3.15M | New |
| 2 | Commodore Capital LP | 2.33M | $7.98M | +2.33M | New |
| 3 | Millennium Management LLC | 2.22M | $7.60M | +2.13M | Added |
| 4 | Spruce Street Capital LP | 1.66M | $5.58M | +1.66M | New |
| 5 | Almitas Capital LLC | 1.48M | $5.06M | 0 | Held |
| 6 | Adage Capital Partners Gp, L.L.C. | 1.00M | $3.42M | +1.00M | New |
| 7 | Woodline Partners LP | 993.7K | $3.40M | +847.7K | Added |
| 8 | Boxer Capital Management, LLC | 749.0K | $2.56M | +749.0K | New |
| 9 | Stonepine Capital Management, LLC | 713.8K | $2.44M | +86.2K | Added |
| 10 | Ameriprise Financial Inc | 696.2K | $2.38M | +696.2K | New |
39 more institutional holders on Premium
See every fund holding An2 Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders